| 2种用药方案治疗社区获得性肺炎的成本-效果分析 |
| |
| 引用本文： | 张玉娥,韦超霞.2种用药方案治疗社区获得性肺炎的成本-效果分析[J].中国执业药师,2010,7(5):24-26. |
| |
| 作者姓名： | 张玉娥 韦超霞 |
| |
| 作者单位： | 1. 广东江门市五邑中医院/暨南大学医学院第六附属医院临床药学室,广东江门,529000
2. 桂林医学院,广西,桂林,541004 |
| |
| 摘 要： | 目的：探讨2种药物治疗方案对社区获得性肺炎的经济效果。方法：采用回顾性研究方法,选择88例社区获得性肺炎患者,分别给予头孢哌酮钠/舒巴坦钠组（A组）、左氧氟沙星组（B组）,观察2组疗效并进行成本-效果分析。结果：A组与B组成本分别为1803.91、1599.81元（P〉0.05）,有效率分别为95.0%、100.0%（P〉0.05）,成本-效果比分别为1898.85、1599.81。结论：B组方案优于A组方案。
|
| 关 键 词： | 社区获得性肺炎 头孢哌酮/舒巴坦钠 左氧氟沙星 成本-效果分析 |
Cost-Effectiveness Analysis of Cefoperazone Sodium/Sulbactam Sodium vs Levofloxacin in the Treatment of Community Acquired Pneumonia |
| |
| Authors: | Zhang Yu＇e Wei Chaoxia |
| |
| Institution: | 1 Dept. of Clinical Pharmacy, Guangdong Jiangmen Municipal Wuyi Hospital of TCM ＆ The Sixth Affiliated Hospital of Medical College of Ji＇nan University, Jiangmen 529000,China; 2 Guilin Medical College, Guilin 541004, China) |
| |
| Abstract: | Objective：To evaluate the cost-effectiveness of two therapeutic schemes in the treatment of community acquired pneumonia. Methods： A retrospective study was conducted in which a total of 88 cases with community acquired pneumonia were randomly assigned to receive cefoperazone sodium/sulbactam sodium（Group A） or levofloxacin（Group B）. The therapeutic effects were monitored and the cost-effectiveness analysis were conducted on the two group. Results： The cost was 1803.91 yuan in Group A versus 1599.81 yuan in Group B（P0.05）; the effective rates were 95.0% versus 100.0% （P0.05） and the cost-effectiveness ratios were 1898.85 and 1599.81, respectively. Conclusion： Levoflocaxin is superior to cefoperazone sodium/sulbactam sodium for community acquired pneumonia. |
| |
| Keywords: | Community Acquired Pneumonia Cefoperazone Sodium/Sulbactam Sodium Levofloxacin Cost-Effectiveness Analysis |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
